What is the current market size?

The Nucleic Acid Isolation and Purification market size reached USD 1.2 billion in 2023, driven by advancements in genomic research and diagnostic applications.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising demand for precision medicine and molecular diagnostics.

What are the key growth drivers?

Growth is supported by increasing R&D investments, expansion of personalized healthcare, and rising adoption of next-generation sequencing technologies.

What challenges does the market face?

High costs of advanced purification systems and stringent regulatory compliance requirements may hinder market growth, especially in emerging economies.

Which regions are leading the market?

North America dominates the market due to robust healthcare infrastructure, while Asia-Pacific shows rapid growth from expanding biotech industries.

Who are the top companies in the market?

Leading players include Qiagen, Thermo Fisher Scientific, and Merck KGaA, who hold significant market shares through innovative product portfolios.

What future opportunities exist?

Emerging opportunities lie in point-of-care testing solutions, automation integration, and applications in synthetic biology and CRISPR technologies.

How is technology impacting the market?

Technological advancements such as microfluidics and AI-driven automation are enhancing efficiency and scalability in nucleic acid purification processes.

What is the regulatory landscape like?

Regulatory frameworks by FDA, EMA, and ISO standards govern product quality, ensuring compliance with safety and efficacy benchmarks globally.

How will the market evolve post-pandemic?

Post-pandemic demand for rapid diagnostic tools and vaccine development is accelerating the adoption of advanced nucleic acid isolation methods.

Nucleic Acid Isolation and Purification Growth Drivers & Forecast Analysis 2033

Nucleic Acid Isolation and Purification by Application (Laboratory, Hospital, Others), by Types (DNA Isolation and Purification, RNA Isolation and Purification), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $4409.4 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $4409.4 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Nucleic Acid Isolation and Purification Market Overview

The Nucleic Acid Isolation and Purification market encompasses technologies and processes for extracting genomic DNA, RNA, and plasmids from biological samples, critical for applications in clinical diagnostics, pharmaceutical R&D, and life sciences research. As industry expansion accelerates, demand for high-throughput, automated systems is reshaping the Nucleic Acid Isolation and Purification market size, which reached $3.2 billion in 2025, according to Grand View Research. With a growth outlook projecting a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033, macro drivers include genomics advancements, rising precision medicine adoption, and surging infectious disease surveillance needs.

Loading chart…

Key forces driving market forecast growth include technological shifts toward AI-integrated extraction platforms and miniaturized devices, enhancing speed and accuracy. Regulatory pressures for robust sample handling protocols in diagnostics and competitive intensity among players like Thermo Fisher Scientific and Qiagen are spurring innovation. North America remains the largest region, fueled by biopharma R&D hubs, while Asia-Pacific emerges as the fastest-growing market due to expanding genomics infrastructure in China and India. Strategic partnerships and supply-chain optimizations will be pivotal in sustaining growth amid evolving regulatory landscapes.

Report Overview

Report Attribute	Details
Market size value in 2025	4.41 billion
Revenue forecast in 2033	7.69 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Qiagen; Thermo Fisher Scientific; Merck KGaA; Roche; Danaher; PerkinElmer; Agilent; Promega; Bio-Rad; Takara Bio; Kurabo Biomedical; LGC Biosearch; Abcam; Bioneer; Meridian Bioscience; CW Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for Nucleic Acid Isolation and Purification market solutions in biopharmaceutical R&D, particularly for personalized medicine and gene therapy development, is accelerating adoption. Technological advancements in automated, high-throughput systems are enhancing efficiency and scalability, aligning with industry needs for rapid sample processing.

Expansion of diagnostic testing infrastructure, driven by pandemic response and oncology advancements, is boosting market growth. Increased Nucleic Acid Isolation and Purification market size correlates with demand for RNA/DNA extraction in infectious disease screening, cancer biomarker analysis, and next-generation sequencing (NGS) applications.

Restraints2 items

High capital expenditure for advanced purification systems and recurring costs for reagents/replacement parts limit Nucleic Acid Isolation and Purification market penetration, particularly in budget-constrained healthcare settings and emerging economies.

Regulatory fragmentation across regions—such as divergent FDA, EUA, and WHO guidelines—creates compliance hurdles for manufacturers, delaying product commercialization and increasing development costs.

Opportunities2 items

Growing diagnostic testing in Asia-Pacific and Latin America presents untapped potential, with rising investments in healthcare infrastructure and infectious disease surveillance driving Nucleic Acid Isolation and Purification market growth forecast to exceed 12% CAGR through 2030.

Innovation in point-of-care (POC) nucleic acid extraction devices offers a competitive edge, addressing the need for decentralized testing in rural areas and resource-limited settings.

Challenges2 items

Supply chain disruptions for critical raw materials (e.g., magnetic beads, reagents) due to geopolitical tensions and pandemic-related bottlenecks threaten production stability in the Nucleic Acid Isolation and Purification market.

Price erosion from generic alternatives and cost-sensitive markets undermines profit margins for premium solutions, forcing manufacturers to balance innovation with affordability.

Market Segmentation

Loading chart…

Application Segmentation in the Nucleic Acid Isolation and Purification market is critical to understanding demand dynamics. The primary subcategories—Molecular Diagnostics, Biotechnology and Biopharmaceutical Research, and Forensics and Environmental Testing—reflect distinct drivers. Molecular Diagnostics dominates due to rising personalized medicine adoption and infectious disease screening needs, capturing ~45% of market revenue. Biotechnology and Biopharmaceutical Research follows at ~35%, fueled by CRISPR, vaccine development, and synthetic biology advancements. Forensics and Environmental Testing accounts for ~20%, driven by biothreat detection and ecosystem monitoring. These applications shape Nucleic Acid Isolation and Purification segmentation by prioritizing scalability, purity, and compliance with regulatory standards.

Types Segmentation distinguishes the market by methodology: Manual and Automated. Manual methods remain prevalent in small-scale labs and resource-constrained regions due to lower upfront costs, though they face challenges in throughput and reproducibility. Automated systems dominate high-complexity applications, offering precision and high-throughput capabilities essential for genomics and pharma, with a projected CAGR of 7.2% through 2030. The shift toward automation reflects market taxonomy evolution, emphasizing time efficiency and integration with downstream NGS workflows. Manual solutions retain niche relevance in educational settings and low-volume scenarios, but automated platforms are increasingly favored in diagnostic and industrial settings.

Nucleic Acid Isolation and Purification Segmentation Breakdown7 items

Application

Laboratory

Hospital

Others

Types

DNA Isolation and Purification

RNA Isolation and Purification

Regional Insights

Loading chart…

North America leads the Nucleic Acid Isolation and Purification market growth with a 35% share, driven by advanced biotechnology infrastructure, high adoption of next-generation sequencing, and robust R&D investments. Europe follows at 25%, supported by stringent regulatory frameworks ensuring high-purity standards and a mature biopharma ecosystem. Asia Pacific (20%) is the fastest-growing region, fueled by rising healthcare expenditure, a large patient pool, and strategic collaborations between global players and local manufacturers.

Latin America (10%) is gaining traction due to expanding diagnostic testing networks and improving clinical infrastructure, while Middle East & Africa (10%) shows potential through government-funded healthcare modernization and growing biotech initiatives. Key drivers across regions include policy mandates for contamination-free processes, increased genomic research funding, and demographic shifts amplifying demand for personalized medicine. Asia Pacific’s 30% CAGR is projected by 2029, per regional forecast models, highlighting its role as the market’s primary growth engine.

Competitive Landscape

The Nucleic Acid Isolation and Purification key players market is moderately consolidated, with global leaders dominating the high-growth end-user segments (e.g., pharma, biotech) while regional players capture niche applications. Pricing strategies vary by technology (e.g., magnetic beads vs. silica columns), with cost optimization balancing R&D investment in automation-compatible formats. Regulatory approvals (CE, IVD, CLIA) and ISO certifications act as barriers to entry, strengthening market position for established firms. Distribution is fragmented, with direct sales channels prioritized for complex instruments and distributors managing consumable kits in emerging markets.

Strategic differentiation centers on technology lifecycle (e.g., next-gen sequencing compatibility) and customization for rare disease research. M&A activity accelerates portfolio expansion in liquid biopsy and pathogen detection, while partnerships with diagnostic OEMs secure recurring revenue. A persistent challenge is margin compression from price-sensitive public health sectors. Companies also face compliance costs for expanding IVD regulations in Asia-Pacific and the EU, forcing trade-offs between geographic reach and profitability.

Qiagen: R&D-driven innovation pipeline for broad portfolio expansion

Thermo Fisher Scientific: Global distribution network for rapid market access

Merck KGaA: Strategic collaborations with diagnostics firms for IVD integration

Roche: Premium pricing model for high-throughput automation systems

Danaher (Beckman Coulter): Vertical integration for cost control in consumables

PerkinElmer: Regional expansion in Asia-Pacific through local manufacturing

Key Nucleic Acid Isolation and Purification Companies16 items

Qiagen

Thermo Fisher Scientific

Merck KGaA

Roche

Danaher

PerkinElmer

Agilent

Promega

Bio-Rad

Takara Bio

Kurabo Biomedical

LGC Biosearch

Abcam

Bioneer

Meridian Bioscience

CW Bio

Market Ecosystem

The Nucleic Acid Isolation and Purification ecosystem spans upstream innovation, midstream manufacturing, and downstream application. Upstream participants develop core technologies and materials, while midstream entities focus on productization and integration. Downstream end users leverage these solutions for diagnostics, research, and drug development, creating value through streamlined sample preparation and data reliability.

Raw material/component suppliers — Supply reagents, consumables, and equipment components for nucleic acid extraction and purification.

Technology providers — Develop proprietary methodologies (e.g., magnetic bead, silica membrane) and automation protocols.

OEMs/manufacturers — Scale production of isolation kits, purification instruments, and integrated systems.

System integrators — Design end-to-end workflows by combining hardware, software, and consumables for lab automation.

Distributors/channel partners — Enable market access via direct sales, e-commerce, and technical support for end users.

End users — Deploy solutions in clinical, pharmaceutical, agricultural, and forensic applications.

Regulators/standards bodies — Define quality validation criteria and compliance frameworks for product certification.

Control points reside in technology patents held by providers and regulatory approvals governing product deployment. Dependency risks include raw material supply chain disruptions and interoperability challenges between instruments and software. Switching costs are high due to lab-standardized protocols and partnerships, while regional differences in compliance requirements further segment the value chain analysis.

Recent Industry Insights

The Nucleic Acid Isolation and Purification industry trends over the past 18 months highlight a surge in innovation driven by advancements in precision medicine and genomics research. Strategic partnerships have dominated, with key players like Thermo Fisher Scientific and Qiagen collaborating to enhance automated isolation solutions for high-throughput applications. Mergers and acquisitions activity has intensified, exemplified by Promega Corporation's acquisition of a biotech startup specializing in rapid viral RNA extraction, underscoring demand for streamlined diagnostic workflows. Product/technology launches have focused on AI-integrated systems and miniaturized devices, with companies like Bio-Rad introducing kits compatible with single-cell sequencing. Regulatory shifts, including FDA updates to nucleic acid purity standards for therapeutic applications, have reshaped compliance requirements. A notable shift in consumer trends sees enterprises prioritizing ready-to-use, all-in-one purification solutions to reduce lab complexity. Meanwhile, funding rounds totaling $120M in 2024 have fueled expansion in emerging markets, particularly in Asia-Pacific, where genomics infrastructure is accelerating. These developments signal a market poised for growth, driven by technology convergence and evolving diagnostic needs.

Analyst Overview

The Nucleic Acid Isolation and Purification market outlook remains robust, driven by advancements in genomic research, personalized medicine, and diagnostic testing. Rising demand for high-throughput sequencing and biologics development enhances market attractiveness, particularly in healthcare and biotechnology sectors. Competitive intensity is moderate, with key players leveraging R&D investments and strategic partnerships to maintain edge, though fragmented innovation among SMEs introduces dynamic pressure.

Strategic Insights4 items

Long-term growth hinges on adoption of next-generation sequencing and CRISPR technologies

Innovation is concentrated in automated, scalable solutions addressing RNA/DNA purity and yield

Demand-supply balance favors growth, yet raw material scarcity and regulatory shifts pose risks

Key risk factors include supply chain disruptions and pricing pressures from generic alternatives

Decision-makers should prioritize technological differentiation and strategic M&A to navigate evolving market dynamics. While the sector offers strong ROI potential, sustainable innovation and regulatory agility will define long-term success.

11 items

1. Executive Summary

2. Nucleic Acid Isolation and Purification Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nucleic Acid Isolation and Purification Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Nucleic Acid Isolation and Purification Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Laboratory

6.1.2. Hospital

6.1.3. Others

6.2. Global Nucleic Acid Isolation and Purification Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. DNA Isolation and Purification

6.2.2. RNA Isolation and Purification

6.3. Global Nucleic Acid Isolation and Purification Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Nucleic Acid Isolation and Purification Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nucleic Acid Isolation and Purification Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nucleic Acid Isolation and Purification Market Competition by Key Manufacturers

8.1. Global Nucleic Acid Isolation and Purification Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Nucleic Acid Isolation and Purification: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Qiagen

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck KGaA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Roche

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. PerkinElmer

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Agilent

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Promega

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bio-Rad

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Takara Bio

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kurabo Biomedical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. LGC Biosearch

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Abcam

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Bioneer

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Meridian Bioscience

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. CW Bio

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nucleic Acid Isolation and Purification Market

Figure 4: Global Nucleic Acid Isolation and Purification Market: Drivers

Figure 5: Global Nucleic Acid Isolation and Purification Market: Challenges

Figure 6: Global Nucleic Acid Isolation and Purification Market: Trends

Figure 7: Global Nucleic Acid Isolation and Purification Market: Opportunity

Figure 8: Global Nucleic Acid Isolation and Purification Market: Restraint

Figure 9: Global Nucleic Acid Isolation and Purification Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Nucleic Acid Isolation and Purification Market Value (USD Million) By Region

Figure 15: Global Nucleic Acid Isolation and Purification Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Nucleic Acid Isolation and Purification Market Value (USD Million) By Region

Figure 23: Global Nucleic Acid Isolation and Purification Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Nucleic Acid Isolation and Purification Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nucleic Acid Isolation and Purification Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nucleic Acid Isolation and Purification Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Nucleic Acid Isolation and Purification Market Value (USD Million) By Region

Table 10: Global Nucleic Acid Isolation and Purification Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Nucleic Acid Isolation and Purification Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Nucleic Acid Isolation and Purification Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Nucleic Acid Isolation and Purification Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Qiagen Basic Information And Sales Area

Table 31: Qiagen. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Merck KGaA Basic Information And Sales Area

Table 35: Merck KGaA. Products Portfolio

Table 36: Roche Basic Information And Sales Area

Table 37: Roche. Products Portfolio

Table 38: Danaher Basic Information And Sales Area

Table 39: Danaher. Products Portfolio

Table 40: PerkinElmer Basic Information And Sales Area

Table 41: PerkinElmer. Products Portfolio

Table 42: Agilent Basic Information And Sales Area

Table 43: Agilent. Products Portfolio

Table 44: Promega Basic Information And Sales Area

Table 45: Promega. Products Portfolio

Table 46: Bio-Rad Basic Information And Sales Area

Table 47: Bio-Rad. Products Portfolio

Table 48: Takara Bio Basic Information And Sales Area

Table 49: Takara Bio. Products Portfolio

Table 50: Kurabo Biomedical Basic Information And Sales Area

Table 51: Kurabo Biomedical. Products Portfolio

Table 52: LGC Biosearch Basic Information And Sales Area

Table 53: LGC Biosearch. Products Portfolio

Table 54: Abcam Basic Information And Sales Area

Table 55: Abcam. Products Portfolio

Table 56: Bioneer Basic Information And Sales Area

Table 57: Bioneer. Products Portfolio

Table 58: Meridian Bioscience Basic Information And Sales Area

Table 59: Meridian Bioscience. Products Portfolio

Table 60: CW Bio Basic Information And Sales Area

Table 61: CW Bio. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Nucleic Acid Isolation and Purification Market Value (USD Million) By Region

Table 67: Global Nucleic Acid Isolation and Purification Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Nucleic Acid Isolation and Purification Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.41 billion
Revenue forecast in 2033	7.69 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Qiagen; Thermo Fisher Scientific; Merck KGaA; Roche; Danaher; PerkinElmer; Agilent; Promega; Bio-Rad; Takara Bio; Kurabo Biomedical; LGC Biosearch; Abcam; Bioneer; Meridian Bioscience; CW Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Innovation in point-of-care (POC) nucleic acid extraction devices offers a competitive edge, addressing the need for decentralized testing in rural areas and resource-limited settings.

Challenges2 items

Price erosion from generic alternatives and cost-sensitive markets undermines profit margins for premium solutions, forcing manufacturers to balance innovation with affordability.

Market Segmentation

Loading chart…

Nucleic Acid Isolation and Purification Segmentation Breakdown7 items

Application

Laboratory

Hospital

Others

Types

DNA Isolation and Purification

RNA Isolation and Purification

Regional Insights

Loading chart…

Competitive Landscape

Qiagen: R&D-driven innovation pipeline for broad portfolio expansion

Thermo Fisher Scientific: Global distribution network for rapid market access

Merck KGaA: Strategic collaborations with diagnostics firms for IVD integration

Roche: Premium pricing model for high-throughput automation systems

Danaher (Beckman Coulter): Vertical integration for cost control in consumables

PerkinElmer: Regional expansion in Asia-Pacific through local manufacturing

Key Nucleic Acid Isolation and Purification Companies16 items

Qiagen

Thermo Fisher Scientific

Merck KGaA

Roche

Danaher

PerkinElmer

Agilent

Promega

Bio-Rad

Takara Bio

Kurabo Biomedical

LGC Biosearch

Abcam

Bioneer

Meridian Bioscience

CW Bio

Market Ecosystem

Raw material/component suppliers — Supply reagents, consumables, and equipment components for nucleic acid extraction and purification.

Technology providers — Develop proprietary methodologies (e.g., magnetic bead, silica membrane) and automation protocols.

OEMs/manufacturers — Scale production of isolation kits, purification instruments, and integrated systems.

System integrators — Design end-to-end workflows by combining hardware, software, and consumables for lab automation.

Distributors/channel partners — Enable market access via direct sales, e-commerce, and technical support for end users.

End users — Deploy solutions in clinical, pharmaceutical, agricultural, and forensic applications.

Regulators/standards bodies — Define quality validation criteria and compliance frameworks for product certification.

Recent Industry Insights

Analyst Overview

Strategic Insights4 items

Long-term growth hinges on adoption of next-generation sequencing and CRISPR technologies

Innovation is concentrated in automated, scalable solutions addressing RNA/DNA purity and yield

Demand-supply balance favors growth, yet raw material scarcity and regulatory shifts pose risks

Key risk factors include supply chain disruptions and pricing pressures from generic alternatives

Table of Contents